Dingdang Health Technology Group Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 1,989.78 million compared to CNY 1,643.61 million a year ago. Net loss was CNY 578.07 million compared to CNY 1,087.5 million a year ago.

Basic loss per share from continuing operations was CNY 0.92 compared to CNY 3.39 a year ago. Diluted loss per share from continuing operations was CNY 0.92 compared to CNY 3.39 a year ago.